Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002313566 | SCV000848653 | uncertain significance | Inborn genetic diseases | 2017-01-18 | criteria provided, single submitter | clinical testing | The p.E830K variant (also known as c.2488G>A), located in coding exon 1 of the RAI1 gene, results from a G to A substitution at nucleotide position 2488. The glutamic acid at codon 830 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV001868350 | SCV002296156 | likely benign | not provided | 2024-09-04 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004742588 | SCV005348516 | uncertain significance | RAI1-related disorder | 2024-03-22 | no assertion criteria provided | clinical testing | The RAI1 c.2488G>A variant is predicted to result in the amino acid substitution p.Glu830Lys. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.0098% of alleles in individuals of Latino descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |